Where Innovative Science and Market Access Meet
Market access advice from market access leaders
LatticePoint is a boutique consulting firm that focuses on pricing and market access for innovative medicines and medical devices. LatticePoint is led by former industry market access leaders who understand how to plan for the political, scientific, and financial realities that will be pivotal in negotiating product access. We work with biopharma companies and investors to help define, negotiate, and defend the value of their products in key markets around the world.
''Access is a game of experience''
Big or small, we adapt to you
Our clients consist of investors and companies in the pre-commercial, commercial, and post-LOE stage across a variety of therapeutic areas and indications, including oncology, rare diseases, cell and gene therapies, radiopharmaceuticals, and many other orphan and non-orphan areas. Whether you need support in fundraising, in-licensing, launching a new medicine or evolving your access team to meet the demands of the future, we have the experience to help you optimize the outcome.
We understand our clients’ needs because we’ve been there.
Our team has significant experience in biomedical and economic sciences, industry, venture capital and negotiating on behalf of clients in various countries. Our work is used for product commercialization, investment valuations, licensing and M&A due diligence.